Summary
An experimental rat model to study acute cytomegalovirus infections is described. Eight-week old male Brown Norway rats, immunosuppressed by total body irradiation, were infected with rat cytomegalovirus (RCMV). The effects of infection were determined by survival rates and the presence of virus or viral components in different organs was assayed by plaque test, immunoperoxidase staining, dot-blot DNA hyridization and in situ DNA hybridization. At days 10-post infection nearly 90% of the animals had died. Spleen, liver and bone marrow were heavily infected. Interstitial pneumonia was observed. Pathological findings strongly resembled the full scale of lesions in human CMV infections. Anti-RCMV hyperimmune serum was effective against mortality from RCMV infection and viral spread to lungs and liver was prevented. This model is appropriate for studies on the pathogenesis and antiviral therapy of CMV infections in the immunocompromised host.
Article PDF
Similar content being viewed by others
References
Ho M (1982) Cytomegalovirus. Biology and infection. Plenum, New York
Meyers JD, Leozczinski J, Zaia JA et al (1983) Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med 98: 442–446
Snydman DR, Werner BG, Heinze Lacey B et al (1987) Use of cytomegalovirus immunoglobulin to prevent cytomegalovirus disease in renal transplant recipients. N Engl J Med 317: 1049–1054
Bia FJ, Griffith BP, Fong CKY, Hsiung GD (1983) Cytomegalovirus infections in the guinea pig: experimental models for human disease. Rev Infect Dis 5: 177–195
Bruggeman CA, Meijer H, Dormans PHJ, Debie WMH, Grauls GELM, van Boven CPA (1982) Isolation of a cytomegalovirus-like agent from wild rats. Arch Virol 73: 231–241
Bruning JH, Bruggeman CA, van Boven CPA, van Breda Vriesman PJC (1986) Passive transfer of cytomegalovirus by cardiac and renal organ transplants in a rat model. Transplantation 41: 695–698
Bruning JH (1988) Cytomegalovirus infections in renal transplantation. Study in a rat model. PhD Thesis, University of Limburg, Maastricht, The Netherlands
Bruggeman CA, Debie WHM, Grauls G, Majoor G, van Boven CPA (1983) Infection of laboratory rats with a new CMV-like virus. Arch Virol 76: 189–199
Bruning JH, Debie WHM, Dormans PHJ, Meijer H, Bruggeman CA (1987) The development and characterization of monoclonal antibodies against rat cytomegalovirus induced antigens. Arch Virol 94: 55–70
Meijer H, Dormans PHJ, Geelen JLMC, van Boven CPA (1984) Ratcytomegalovirus: Studies on the viral genome and the proteins of virions and nucleocapsids. J Gen Virol 65: 681–695
Meijer H, Dreesen JCFM, van Boven CPA (1986) Molecular cloning and restriction endonuclease mapping of the rat cytomegalovirus genome. J Gen Virol 67: 1327–1342
Birnboim HC, Doly J (1979) A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res 7: 1513–1523
Göbel U, Maas R, Clad A (1987) Quantitative electro elution of oligonucleotides and large DNA fragments from gels and purification by electrodialysis. J Biochem Biophys Methods 14: 245–260
Hendrix MGR, Dormans PHJ, Kitslaar P, Bosman F, Bruggeman CA (1989) The presence of CMV nucleic acids in arterial walls of atherosclerotic and non-atherosclerotic patients. Am J Pathol 134: 1151–1157
Smith LJ, Braylan RC, Natkis JE, Edmunsun KB, Downing JR, Wakeland EK (1987) Extraction of cellular DNA from human cells and tissues fixed in ethanol. Anal Biochem 160: 135–138
Plummer G, Benyesh-Melnick M (1964) A plaque reduction neutralization test for human cytomegalovirus. Proc Soc Exp Biol Med 117: 145–150
Gehan E (1956) Generalized Wilcoxon test for comparing arbitrarity single sensored samples. Biometrica 52: 203–224
Gross AJ, Clark VA (1975) Survival distributions: reliability applications in the biomedical sciences. Wiley, New York, pp 240–250
Bruggeman CA, Meijer H, Bosman F, van Boven CPA (1985) Biology of rat cytomegalovirus infection. Intervirology 24: 1–9
Plotkin SA, Michelson S, Pagano JS, Rapp F (1984) CMV: pathogenesis and prevention of human infection. Birth Defects 20: 65–74
Katzenstein DA, Yu GSM, Jordan MC (1983) Lethal infection with murine cytomegalovirus after early viral repliation in the spleen. J Infect Dis 145: 406–411
Buckley PJ, Dicson SA, Walker WS (1985) Human splenic sinusoidal lining cells express antigens associated with monocytes, macrophages, endothelial cells, and T lymphocytes. J Immunol 134: 2310–2315
Whyte PF, Subramaniam R, Hudson JB (1987) Characterization of a murine cytomegalovirus-induced immunosuppressive factor. Arch Virol 96: 169–183
Snover DC, Hutton S, Balfour HH, Bloomer JR (1987) Cytomegalovirus infection of the liver in transplant recipients. J Clin Gastroenterol 9, 6: 659–665
Vanstapel M-J, Desmet VJ (1983) Cytomegalovirus hepatitis: a histological and immunohistochemical study. Appl Pathol 1: 41–49
Ten Napel, Chr HH, Houthoff HJ, The TH (1984) Cytomegalovirus hepatitis in normal and immune compromised hosts. Liver 4: 184–194
Wiley CA, Nelson JA (1988) Role of human immunodeficiency virus and cytomegalovirus in AIDS encephalitis. Am J Pathol 133: 73–81
Bale JF, O'Neil ME, Giller R, Perlman S, Koszinowski U (1987) Murine cytomegalovirus genomic material in marrow cells: relation to altered leukocyte counts during sublethal infection of mice. J Infect Dis 155: 207–212
Mutter W, Reddehase MJ, Busch FW, Bühring H-J, Koszinowski UH (1988) Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host. J Exp Med 167: 1645–1658
Bruggeman CA, Grauls G, van Boven CPA (1985) Susceptibility of peritoneal macrophages to rat cytomegalovirus infection. FEMS Microbiol Lett 27: 263–266
Manischewitz JE, Quinnan GV (1980) Antivirus antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection. Infect Immun 29: 1050–1054
Quinnan GV, Manischewitz JE (1979) The role of natural killer cells and antibody dependent cell-mediated cytotoxicity during murine cytomegalovirus infection. J Exp Med 150: 1549–1554
Shanley JD, Jordan MC, Stevens JG (1981) Modification by adoptive humoral immunity of murine cytomegalovirus infection. J Infect Dis 143: 231–237
Rubin RH, Wilson EJ, Barrett LV, Medearis DN (1986) The protective effects of hyperimmune antimurine cytomegalovirus antiserum against lethal viral challenge: the case for passive-active immunization. Clin Immunol Immunopathol 39: 151–158
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stals, F.S., Bosman, F., van Boven, C.P.A. et al. An animal model for therapeutic intervention studies of CMV infection in the immunocompromised host. Archives of Virology 114, 91–107 (1990). https://doi.org/10.1007/BF01311014
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01311014